1Health Technology Assessment Section.Medical Development Division.Ministry of Health Malaysia.Clinical practice guidelines.Management of gout[EB/OL].2008.http://www.moh.gov.my/v/rhe.
2Jordan KM,Cameron JS,Snarth M,et al.British Society for Bheumatology and British health professionals in rheumatology guideline for the management of gout[J].Rheumatology(Oxford),2007,46(8):.1372-1374.
3Luqmani R,Hennell S,Estrach C,et al.British society for rheumatology and British health professionals in rheumatology guideline for the management of rheumatoid arthritis (the first two years)[J].Rheumatology (Oxford),2006,45(9):1167-1169.
4Saag KG,Teng GG,Patkar NM,et al.American college of rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis[J].Arthritis Rheum,2008,59(6):762-784.
5Smolen JS,Landew(e) R,Breedveld FC,et al.EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs[J].Ann Rheum Dis,2010,69(6):964-975.
6van der Heijde D,Sieper J,Maksymowych WP,et al.2010 Update of the international ASAS recommendations for the use of anti-TNF agents in patients with axial spondyloarthritis[J].Ann Rheum Dis,2011,70(6):905-908.
7Sieper J,Rudwaleit M,Baraliakos X,et al.The Assessment of SpondyloArthritis international Society (ASAS) handbook:a guide to assess spondyloarthritis[J].Ann Rheum Dis,2009,68 Suppl 2:iil-ii44.
8Bertsias G,Ioannidis JP,Boletis J,et al.EULAR recommendations for the management of systemic lupus erythematosus.Report of a task force of the EULAR standing committee for international clinical studies including therapeutics[J].Ann Rheum Dis,2008,67(2):195-205.
9Bertsias GK,Ioannidis JP,Aringer M,et al.EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations:report of a task force of the EULAR standing committee for clinical affairs[J].Ann Rheum Dis,2010,69(12):2074-2082.
10Lee YH,Woo J-H,Choi SJ,et al.Induction and maintenance therapy for lupus nephritis:a systematic review and meta-analysis[J].Lupus,2010,19(6):703-710.
